Translation of "overt diabetes" to Portuguese language:
Dictionary English-Portuguese
Diabetes - translation : Overt - translation : Overt diabetes - translation :
Examples (External sources, not reviewed)
| If overt diabetes occurs, growth hormone should not be administered. | Em caso de detecção de diabetes, não se deve administrar a hormona do crescimento. |
| If overt diabetes occurs, growth hormone should not be administered. | Em caso de deteção de diabetes, não se deve administrar a hormona do crescimento. |
| Women who use insulin, with a history of stillbirth, or with hypertension are managed like women with overt diabetes. | Como no DM tipo 2, as mulheres que desenvolvem o DMG são aquelas com sobrepeso ou obesidade. |
| Overt signs of bleeding | Sinais declarados de hemorragia |
| Overt cardiac failure, cardiogenic shock. | Insuficiência cardíaca manifesta, choque cardiogénico. |
| In addition, rosiglitazone preserved ß cell function as shown by increased pancreatic islet mass and insulin content and prevented the development of overt hyperglycaemia in animal models of type 2 diabetes. | Além disso, em modelos animais de diabetes tipo 2, a rosiglitazona preservou a função das células β, o que é demonstrado pelo aumento da massa dos ilhéus pancreáticos e do seu conteúdo em insulina, e preveniu o desenvolvimento de hiperglicemia declarada. |
| In addition, rosiglitazone preserved ß cell function as shown by increased pancreatic islet mass and insulin content and prevented the development of overt hyperglycaemia in animal models of type 2 diabetes. | Além disso, em modelos animais de diabetes tipo 2, a rosiglitazona preservou a função das células β, o que é demonstrado pelo aumento do conteúdo da massa dos ilhéus pancreáticos e do seu conteúdo em insulina, e preveniu o desenvolvimento de hiperglicemia declarada. |
| In addition, rosiglitazone preserved ß cell function as shown by increased pancreatic islet mass and insulin content and prevented the development of overt hyperglycaemia in animal models of type 2 diabetes. | Além disso, em modelos animais de diabetes tipo 2, a rosiglitazona preservou a função das células , o que é demonstrado pelo aumento da massa dos ilhéus pancreáticos e do seu conteúdo em insulina, e preveniu o desenvolvimento de hiperglicemia declarada. |
| In addition, rosiglitazone preserved ß cell function as shown by increased pancreatic islet mass and insulin content and prevented the development of overt hyperglycaemia in animal models of type 2 diabetes. | Além disso, em modelos animais de diabetes tipo 2, a rosiglitazona preservou a função das células , o que é demonstrado pelo aumento do conteúdo da massa dos ilhéus pancreáticos e do seu conteúdo em insulina, e preveniu o desenvolvimento de hiperglicemia declarada. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT ) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | 8 Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT ) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | 19 Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT ) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | 30 Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT ) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | 41 Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT ) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | 52 Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT ) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | 63 Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT ) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| Hypertension and type 2 diabetes with renal disease The Irbesartan Diabetic Nephropathy Trial (IDNT) shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. | Hipertensão e diabetes do tipo 2 com doença renal O Irbesartan Diabetic Nephropathy Trial (IDNT) mostra que o irbesartan diminui a progressão da doença renal em doentes com insuficiência renal crónica e proteinúria evidente. |
| The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinúria evidente em doentes com microalbuminuria. |
| The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinúria evidente em doentes com microalbuminúria. |
| 8 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 18 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 28 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 38 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 48 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 58 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 ) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 8 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 18 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 28 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 38 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 48 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| 58 The study of the Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. | O estudo Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) mostra que 300 mg de irbesartan atrasa a progressão para proteinuria evidente em doentes com microalbuminuria. |
| Diabetes, aggravated diabetes | Diabetes, agravamento de diabetes Muito raros |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Doenças do metabolismo e da nutrição Muito frequentes |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Lúpus eritematoso sistémico, vasculite, artrite reumatóide Desconhecido |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Doenças do sangue e do sistema linfático Muito frequentes |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Doenças do metabolismo e da nutrição Anorexia Muito frequentes |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Doenças do metabolismo e da nutrição me |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Doenças endócrinas me |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Diabetes, agravamento de diabetes Muito raros |
| Hypothyroidism , hyperthyroidism Diabetes, aggravated diabetes | Hipotiroidismo , hipertiroidismo Diabetes, agravamento de diabetes |
| No overt cases of pancreatitis have been reported in this patient population. | Não foram registados casos explícitos de pancreatite nesta população |
| No overt cases of pancreatitis have been reported in this patient population. | Não foram registados casos explícitos de pancreatite nesta população de doentes. |
| None of these patients had overt clinical consequences resulting from weight loss. | Nenhum destes doentes teve consequências clínicas observáveis resultantes da perda de peso. |
Related searches : Overt Operation - Overt Action - Overt Covert - Overt Racism - Less Overt - Overt Expression - Overt Display - Overt Form - Overt Bleeding - Overt Disease - Clinically Overt - Overt Response
